Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab - Concepedia

Concepedia

Publication | Closed Access

Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab

67

Citations

0

References

2017

Year

Yoshihiko Taniguchi, Akihiro Tamiya, Syun-Ichi Isa, Kenji Nakahama, Kyoichi Okishio, Takayuki Shiroyama, Hidekazu Suzuki, Takako Inoue, Motohiro Tamiya, Tomonori Hirashima,

Anticancer Research

Abstract

PS score ≥2, steroid use at baseline and a high LDH level were predictive of poor PFS in patients with NSCLC treated with nivolumab. Careful monitoring is recommended for treating such patients with nivolumab (UMIN-ID: UMIN000025908).